title: Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.
abstract: The serotonin 5-HT(2A) receptor is a primary target of psychedelic hallucinogens such as lysergic acid diethylamine, mescaline, and psilocybin, which reproduce some of the core symptoms of schizophrenia. An incompletely resolved paradox is that only some 5-HT(2A) receptor agonists exhibit hallucinogenic activity, whereas structurally related agonists with comparable affinity and activity lack such a psychoactive activity. Using a strategy combining stable isotope labeling by amino acids in cell culture with enrichment in phosphorylated peptides by means of hydrophilic interaction liquid chromatography followed by immobilized metal affinity chromatography, we compared the phosphoproteome in HEK-293 cells transiently expressing the 5-HT(2A) receptor and exposed to either vehicle or the synthetic hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) or the nonhallucinogenic 5-HT(2A) agonist lisuride. Among the 5995 identified phosphorylated peptides, 16 sites were differentially phosphorylated upon exposure of cells to DOI versus lisuride. These include a serine (Ser(280)) located in the third intracellular loop of the 5-HT(2A) receptor, a region important for its desensitization. The specific phosphorylation of Ser(280) by hallucinogens was further validated by quantitative mass spectrometry analysis of immunopurified receptor digests and by Western blotting using a phosphosite specific antibody. The administration of DOI, but not of lisuride, to mice, enhanced the phosphorylation of 5-HT(2A) receptors at Ser(280) in the prefrontal cortex. Moreover, hallucinogens induced a less pronounced desensitization of receptor-operated signaling in HEK-293 cells and neurons than did nonhallucinogenic agonists. The mutation of Ser(280) to aspartic acid (to mimic phosphorylation) reduced receptor desensitization by nonhallucinogenic agonists, whereas its mutation to alanine increased the ability of hallucinogens to desensitize the receptor. This study reveals a biased phosphorylation of the 5-HT(2A) receptor in response to hallucinogenic versus nonhallucinogenic agonists, which underlies their distinct capacity to desensitize the receptor.
authors.affiliation: CNRS, UMR-5203, Institut de Génomique Fonctionnelle, F-34094 Montpellier, France;
authors.forename: Samah
authors.initials: S
authors.lastname: Karaki
authors.forename: Carine
authors.initials: C
authors.lastname: Becamel
authors.forename: Samy
authors.initials: S
authors.lastname: Murat
authors.forename: Clotilde
authors.initials: C
authors.lastname: Mannoury la Cour
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Millan
authors.forename: Laurent
authors.initials: L
authors.lastname: Prézeau
authors.forename: Joël
authors.initials: J
authors.lastname: Bockaert
authors.forename: Philippe
authors.initials: P
authors.lastname: Marin
authors.forename: Franck
authors.initials: F
authors.lastname: Vandermoere
mesh_terms: D000662:Amphetamines / Q000494:pharmacology*; D000818:Animals; D002478:Cells, Cultured; D005786:Gene Expression Regulation / Q000187:drug effects; D057809:HEK293 Cells; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D008090:Lisuride / Q000494:pharmacology*; D051379:Mice; D009474:Neurons / Q000378:metabolism; D010766:Phosphorylation; D017397:Prefrontal Cortex / Q000378:metabolism; D040901:Proteomics / Q000379:methods; D044402:Receptor, Serotonin, 5-HT2A / Q000378:metabolism*; D012694:Serine / Q000378:metabolism*; D058826:Serotonin 5-HT2 Receptor Agonists / Q000494:pharmacology*; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D000662:Amphetamines; D006213:Hallucinogens; D044402:Receptor, Serotonin, 5-HT2A; D058826:Serotonin 5-HT2 Receptor Agonists; D012694:Serine; D008090:Lisuride; C015952:4-iodo-2,5-dimethoxyphenylisopropylamine